RYAAYRyanair Holdings plc

Neurocrine Biosciences earns Bull of the Day on rising earnings forecasts, while Ryanair is Bear of the Day as weaker fares and cost pressures weigh on outlook.

Until earnings estimate revisions stabilize and pricing trends improve, there may be more downside risk ahead for Ryanair stock (RYAAY).

Ryanair has declined over the past six months as rising costs, macro uncertainty and weaker earnings estimates raise fresh questions about its near-term outlook.

CPA posts May 2025 traffic with RPM up 17% while load factor rose to 88.2% as demand outpaces capacity growth.

LTM posts double-digit May 2026 traffic and capacity growth, signaling growth across all segments, along with a surge in domestic and international markets.

VLRS' May load factor climbed to 86.2% as traffic rose 4.9% and capacity dipped 0.4%, with international gains helping offset softer domestic demand.

RYAAY's passengers rise 6% year over year to 20.7M in May 2026, with load factor flat year over year at 95%.

Ryanair lifts its fiscal 2027 traffic outlook to 216M passengers, signaling stronger demand and raising investor interest in the airline's momentum.

RYAAY faces pressure from rising operating costs and macro uncertainty, as earnings estimates fall and shares lag peers and the S&P 500.